CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2, Randomized, Double-blind, Placebo-controlled Study of Hesperidin Therapy on COVID-19 Symptoms: The Hesperidin Coronavirus Study (Hesperidin)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04715932
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:43.245381+00:00
Published At: 2022-04-08T00:00:00+00:00
Record Updated At: 2022-04-08
Results Posted At: 2022-04-08
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Covid19", "Anosmia", "Fever", "Cough", "Shortness of Breath", "Sore Throat", "Nausea", "Vomiting", "Headache", "Muscle Weakness", "Pain, Muscle", "Pain, Chest", "Pain, Joint", "Pain, Abdominal", "Pain", "Irritable Mood", "Confusion"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-04-08"
protocolSection.identificationModule.nctId: "NCT04715932"
protocolSection.identificationModule.officialTitle: "A Phase 2, Randomized, Double-blind, Placebo-controlled Study of Hesperidin Therapy on COVID-19 Symptoms: The Hesperidin Coronavirus Study (Hesperidin)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2022-04-08"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.